Skip to menu Skip to content Skip to footer

2000

Journal Article

Expression of cytokines and factors modulating apoptosis by human sinusoidal leucocytes

Jonsson, J. R., Edwards-Smith, C. J., Catania, S. C., Morotomi, Y., Hogan, P. G., Clouston, AD, Bansal, A. S., Lynch, S. V., Strong, R. W. and Powell, E. E. (2000). Expression of cytokines and factors modulating apoptosis by human sinusoidal leucocytes. Journal of Hepatology, 32 (3), 392-398. doi: 10.1016/S0168-8278(00)80388-8

Expression of cytokines and factors modulating apoptosis by human sinusoidal leucocytes

2000

Conference Publication

Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model

Jonsson, J. R., Powell, E., Ando, Y., Kelemen, L. and Clouston, A. D. (2000). Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model. Australian Gastroenterology Week 2000, Hobart, 18-21 Oct, 2000. Melbourne: Blackwell Scientific.

Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model

2000

Journal Article

Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel

Demetris, A., Adams, D., Bellamy, C., Blakolmer, K., Clouston, A. D., Dhillon, A. P., Fung, J., Gouw, A., Gustafsson, B., Haga, H., Harrison, D., Hart, J., Hubscher, S., Jaffe, R.A., Khettry, U., Lassman, C., Lewin, K., Martinez, O., Nakazawa, Y., Neil, D., Pappo, O., Parizhskaya, M., Randhawa, P., Rasoul-Rockenschaub, S., Reinholt, F., Reynes, M., Robert, M., Tsamandas, A., Wanless, I. and Wiesner, R. (2000). Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology, 31 (3), 792-799.

Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel

2000

Conference Publication

Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model

Jonsson, J. R., Ando, Y., Kelemen, L., Clouston, A. D. and Powell, E. (2000). Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model. American Association for Study of Liver Disease, Dallas, U.S.A., 27-31 Oct, 2000. Orlando, U.S.A.: WB Saunders.

Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model

2000

Conference Publication

Update of the international Banff schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection

Demetris, Anthony, Adams, David, Bellamy, Chris, Blakolmer, Karin, Clouston, Andrew, Dhillon, Amar Paul, Fung, John, Gouw, Annette, Gustafsson, Bengt, Haga, Hironori, Harrison, David, Hart, John, Hubscher, Stefan, Jaffe, Ron, Khettry, Urmila, Lassman, Charles, Lewin, Klaus, Martinez, Olivia, Nakazawa, Yuichi, Neil, Desley, Pappo, Orit, Parizhskaya, Maria, Randhawa, Parmjeet, Rasoul-Rockenschaub, Susanne, Reinholt, Finn, Reynes, Michel, Robert, Marie, Tsamandas, Athanassios, Wanless, Ian ... Yamabe, Hirohiko (2000). Update of the international Banff schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. W.B. Saunders. doi: 10.1002/hep.510310337

Update of the international Banff schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection

1999

Journal Article

Correspondence: Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients

Jonsson, J. R., Hourigan, L. F., Purdie, D. M., Clouston, A. D., Macdonald, G. A. and Powell, E. E. (1999). Correspondence: Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients. Hepatology, 30 (6), 1530-1531. doi: 10.1002/hep.510300625

Correspondence: Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients

1999

Conference Publication

The clinico-pathological features of hepatocellular carcinoma occurring in non-cirrhotic patients

Higgins, C, Clouston, A and Strong, R (1999). The clinico-pathological features of hepatocellular carcinoma occurring in non-cirrhotic patients. PHILADELPHIA: W B SAUNDERS CO.

The clinico-pathological features of hepatocellular carcinoma occurring in non-cirrhotic patients

1999

Journal Article

Case report: Lamivudine therapy for submassive hepatic necrosis due to reactivation of Hepatitis B following chemotherapy

Maguire, C. M., Crawford, D. H. G., Hourigan, L. F., Clouston, A. D., Walpole, E. T. and Powell, E. E. (1999). Case report: Lamivudine therapy for submassive hepatic necrosis due to reactivation of Hepatitis B following chemotherapy. Journal of Gastroenterology and Hepatalogy, 14 (8), 801-803. doi: 10.1046/j.1440-1746.1999.01961.x

Case report: Lamivudine therapy for submassive hepatic necrosis due to reactivation of Hepatitis B following chemotherapy

1999

Journal Article

Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation.

Kubota, T., Thomson, A., Clouston, A. D., Nakazawa, Y., Steadman, C., Kerlin, P., Shimada, H., Balderson, G. A., Lynch, S. V. and Strong, R. W. (1999). Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation.. Journal of Hepatobiliary Pancreatic Surgery, 6 (4), 377-381. doi: 10.1007/s005340050134

Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation.

1999

Conference Publication

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

Ramm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. American Assoc. for the Study of Liver Diseases 50th Annual Meeting, Dallas, Texas, USA, 5 - 9 Nov, 1999. USA: W B Saunders Co..

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

1999

Conference Publication

Clinicopathological analysis of hepatocellular carcinoma arising in non-cirrhotic liver

Higgins, C., Clouston, A. D., Strong, R. W. and Macdonald, G. A. (1999). Clinicopathological analysis of hepatocellular carcinoma arising in non-cirrhotic liver. American Association for the Study of Liver Diseases, Dallas, USA, 5-9 Nov, 1999. Baltimore: Williams & Wilkins.

Clinicopathological analysis of hepatocellular carcinoma arising in non-cirrhotic liver

1999

Journal Article

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

Hourigan, L. F., Macdonald, G. A., Purdie, D., Whitehall, V. L. J., Shorthouse, C., Clouston, A. and Powell, E. E. (1999). Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology, 29 (4), 1215-1219. doi: 10.1002/hep.510290401

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1999

Conference Publication

High grade dysplasia in Barrett's oesophagus

Sanders, G., Smithers, B. M., Gotley, D. C. and Clouston, A. (1999). High grade dysplasia in Barrett's oesophagus. ArrayAustralian Gastroenterology Week 1999, Brisbane Convention Cen., 4-8 Oct, 1999. Carlton, Vic.: Blackwell Science, Asia.

High grade dysplasia in Barrett's oesophagus

1999

Conference Publication

Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases

Ramm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 October,1999. Carlton, Vic: Blackwell Science Asia.

Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases

1999

Conference Publication

Role of donor leukocyte chimerism in establishing the aetiology of neutropenia following liver transplantation

Jonsson, J. R., Gill, D., Hogan, P., Clouston, A. D., Edwards-Smith, C. and Griffin, A. (1999). Role of donor leukocyte chimerism in establishing the aetiology of neutropenia following liver transplantation. -, Canberra, 14th- 16th June, 1999.

Role of donor leukocyte chimerism in establishing the aetiology of neutropenia following liver transplantation

1999

Conference Publication

The effect of anti-TNF-alpha treatment in the rat liver ischaemia/reperfusion model

Saxton, N., Barclay, J., Clouston, A. D. and Fawcett, J. (1999). The effect of anti-TNF-alpha treatment in the rat liver ischaemia/reperfusion model. Transplantation Society of Australia/New Zealand Annual Scientific Meeting, Canberra, 14-16 Jun, 1999. Asia: Blackwell Science.

The effect of anti-TNF-alpha treatment in the rat liver ischaemia/reperfusion model

1999

Journal Article

Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation

Pascoe, A., Kerlin, P., Steadman, C., Clouston, A. D., Jones, D., Powell, L. W., Jazwinska, E. C., Lynch, S. V. and Strong, R. W. (1999). Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation. Gut, 45 (2), 301-305. doi: 10.1136/gut.45.2.301

Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation

1999

Conference Publication

The clinico-pathological features of hepatocellular carcinoma occuring in non-cirrhotic patients

Higgins, C., Clouston, A. D., Strong, R. W. and Macdonald, G. A. (1999). The clinico-pathological features of hepatocellular carcinoma occuring in non-cirrhotic patients. Australian Gastroenterology Week 1999, Brisbane, 4-8 Oct, 1999. Carlton, Vic: Blackwell Science.

The clinico-pathological features of hepatocellular carcinoma occuring in non-cirrhotic patients

1999

Conference Publication

Venous sclerosis and fibrosis in chronic rejection of liver allografts

Nakazawa, Y., Walker, N. I., Lynch, S. V. and Clouston, A. D. (1999). Venous sclerosis and fibrosis in chronic rejection of liver allografts. 5th Banff Consensus Conference of Allograft Pathology, Banff Springs, Canada, 7-12 June, 1999. Internet: Univ. of Pitsburgh Medical Cen..

Venous sclerosis and fibrosis in chronic rejection of liver allografts

1999

Conference Publication

Veno-occlusive lesions in veins in liver allografts and the relationship to progressive venous sclerosis

Nakazawa, Y., Walker, N. I., Kerlin, P., Strong, R. W., Lynch, S. V. and Clouston, A. D. (1999). Veno-occlusive lesions in veins in liver allografts and the relationship to progressive venous sclerosis. As above, Aust. Academy of Science, Canberra, 14-16 Apr, 1999. Carlton, Vic.: Blackwell Science Asia.

Veno-occlusive lesions in veins in liver allografts and the relationship to progressive venous sclerosis